Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long‐term extension study: a descriptive …
R Venturella, AS Lukes, R Wu… - … of Gynecology & …, 2024 - Wiley Online Library
Objective To investigate the effects of 52 weeks of treatment with relugolix combination
therapy (relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) on symptoms of …
therapy (relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) on symptoms of …
O-136 Once-daily relugolix combination therapy results in sustained reduction in symptoms and improved quality of life in women with uterine fibroids treated over 52 …
A Lukes, R Venturella, A Al-Hendy… - Human …, 2021 - academic.oup.com
Study question What is the effect of relugolix combination therapy (Relugolix-CT) on
symptom burden and health-related quality-of-life (HR-QoL) in patients with uterine fibroids …
symptom burden and health-related quality-of-life (HR-QoL) in patients with uterine fibroids …
[HTML][HTML] Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study
EA Stewart, A Al-Hendy, AS Lukes… - American journal of …, 2024 - Elsevier
Background In the LIBERTY Long-Term Extension study, once-daily relugolix combination
therapy (40 mg relugolix, estradiol 1 mg, norethindrone acetate 0.5 mg) substantially …
therapy (40 mg relugolix, estradiol 1 mg, norethindrone acetate 0.5 mg) substantially …
Quality-of-Life Improvement with Relugolix Combination Therapy in Patients with Heavy Menstrual Bleeding Associated with Uterine Fibroids: Results from the Liberty …
A Al-Hendy, EA Stewart, R Venturella, A Poindexter… - Fertility and …, 2020 - fertstert.org
Objective To evaluate the effect of Relugolix combination therapy (Rel-CT) on Quality of Life
(QoL) using the Uterine Fibroid Symptom Health-Related QoL (UFS-QoL) questionnaire, an …
(QoL) using the Uterine Fibroid Symptom Health-Related QoL (UFS-QoL) questionnaire, an …
Relugolix combination therapy significantly reduced menstrual blood loss with first treatment cycle in women with heavy menstrual bleeding associated with uterine …
R Venturella, A Al-Hendy, AS Lukes, J Kang… - Fertility and …, 2020 - fertstert.org
Objective To evaluate the time to treatment response with once-daily Relugolix combination
therapy (Rel-CT), assessed by decrease in menstrual blood loss (MBL) volume observed in …
therapy (Rel-CT), assessed by decrease in menstrual blood loss (MBL) volume observed in …
[HTML][HTML] Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials
EA Stewart, AS Lukes, R Venturella, Y Li… - American journal of …, 2023 - Elsevier
Background Symptomatic uterine fibroids are burdensome to live with; they are associated
with symptom-related distress, affect daily activities, and reduce health-related quality of life …
with symptom-related distress, affect daily activities, and reduce health-related quality of life …
[HTML][HTML] LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids
Background In the pivotal LIBERTY 1 and 2 trials and long-term extension study, once-daily
relugolix combination therapy (40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone …
relugolix combination therapy (40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone …
LIBERTY randomized withdrawal study: 2-year efficacy and safety of relugolix combination therapy in women with heavy menstrual bleeding associated with uterine …
Objective In the pivotal LIBERTY 1 and 2 trials and Long-Term Extension (LTE) study, once-
daily relugolix combination therapy (Rel-CT: relugolix 40 mg, estradiol 1 mg, norethindrone …
daily relugolix combination therapy (Rel-CT: relugolix 40 mg, estradiol 1 mg, norethindrone …
69. Relugolix combination therapy in European women with symptomatic uterine fibroids in the liberty long-term extension (lte) study
R Venturella, A Al-Hendy, T Nyirady, W Decleer… - European Journal of …, 2022 - ejog.org
Introduction and aims: In LIBERTY 1&2, once-daily relugolix combination therapy (Relugolix-
CT; 40mg relugolix, estradiol 1mg, norethindrone acetate 0.5 mg) improved uterine fibroid …
CT; 40mg relugolix, estradiol 1mg, norethindrone acetate 0.5 mg) improved uterine fibroid …
Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary
EA Stewart, AS Lukes, R Venturella… - Journal of …, 2024 - becarispublishing.com
What is this summary about? This is a summary of findings from two research studies
(known as clinical trials). The studies looked at how well a medicine called relugolix …
(known as clinical trials). The studies looked at how well a medicine called relugolix …